OVID: Ovid Therapeutics Inc O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
Ovid Therapeutics Inc. (OVID) ning saxovatli R&D budjetlari bilan jalb qilingan ilmiy xodimlari P/E ning o'sish nisbati dinamikasini shakllantiradi, bunda 0.00 ko'rsatkichi parametr holatini belgilaydi. Biznes qiymati makroiqtisodiyot yoki inflyatsiyadan ko'ra ko'proq sinov natijalari bilan belgilanadi. Faol rivojlanish bosqichidagi innovatsion epilepsiya terapiyasiga e'tibor kompaniyaning yuqori qiymat potensialini tasdiqlaydi.
Ovid Therapeutics Inc (OVID) kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Jamlagan qarzning kapitalga nisbati Ovid Therapeutics Inc.|OVID - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Ovid Therapeutics|OVID - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Ovid Therapeutics|OVID - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli kredit va qarzlari Ovid Therapeutics|Tezkor likvidlik koeffitsiyenti ovidrx.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
OVID - Kompaniyaning sof foydasi|Forvard foyda Ovid Therapeutics Inc.|OVID - P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Ovid Rx|OVID - Narx-foyda va o‘sish multiplikatori|EV/EBITDA multiplikatori Ovid Therapeutics Inc.|OVID - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi to'rtta chorak uchun bir aksiya uchun foyda Ovid Therapeutics|OVID - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik o'zgarishi ovidrx.com|OVID - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Ovid Therapeutics Inc.
- sotishdan tushum va biznes daromadlari ko'rsatkichlari:
Kompaniyaning umumiy tahlili:OVID - Ovid Therapeutics Inc.
Ovid Therapeutics Inc. (OVID) biodatalarni yig'ishni avtomatlashtirish orqali klinik sinovlarni optimallashtirmoqda, bu esa operatsion xarajatlarni kamaytiradi. Bunday innovatsiyalarning samaradorligi P/E koeffitsiyentining prognoz qilingan foyda o'sish sur'atlariga nisbatida aks etadi. Ushbu metrika o'sish birligining qiymatini belgilab, rivojlanish salohiyati past baholangan aktivlarni aniqlaydi. GURU.Markets platformasidagi past baholangan o'sish kompaniyalari qidiruv ko'rsatkichi orqali tahlil qilish, qiymat birlikdan pastga tushgan paytda kirish nuqtalarini aniqlash imkonini beradi.
Ovid Therapeutics Inc. raqobatchilari
O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Biogen Idec|Neurocrine Corp - Narx-foyda va o‘sish multiplikatori|regencellbioscience.com (RGC) - O‘sish sur’atiga tuzatilgan narx-foyda|AXSM - Narxning foydaga va o‘sish sur’atiga nisbati|ACAD (ACADIA Pharmaceuticals Inc.) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Xenon Pharmaceuticals (XENE) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti VKTX|Narxning foydaga va o‘sish sur’atiga nisbati Supernus|O‘sish sur’atiga tuzatilgan narx-foyda catalystpharma.com CPRX|Narx-foyda va o‘sish multiplikatori DNLI (Denali Therapeutics Inc.)|HRMY - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Biohaven Ltd. BHVN|AMLX (Amylyx) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Trevi Therapeutics Inc - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti PRAX (Praxis Precision Medicines)|AVXL: PEG multiplikatori|CBLL - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati prothena.com|Narx-foyda va o‘sish multiplikatori Alector (ALEC)|Narx-foyda va o‘sish multiplikatori ANNX (annexonbio.com)|OMER - O‘sish sur’atiga tuzatilgan narx-foyda|PEG multiplikatori NGNE (Neurogene Inc)|PEG multiplikatori AC Immune S.A. ACIU|VYGR - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati NMRA|SCLX (Scilex Holding Company) - Narx-foyda va o‘sish multiplikatori|TVGN (Tevogen Bio Holdings) - Narxning foydaga va o‘sish sur’atiga nisbati|ACOG (Alpha Cognition Corp) - PEG multiplikatori|Cognition Therapeutics, Inc. - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori IKT|SAVA (Cassava) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Assertio Holdings, Inc. - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti COYA|VistaGen Therapeutics, Inc. - PEG multiplikatori|Acumen Pharmaceuticals, Inc. (ABOS) - Narx-foyda va o‘sish multiplikatori|CRVO (CervoMed, Inc.) - Narx-foyda va o‘sish multiplikatori|Narx-foyda va o‘sish multiplikatori Alterity Therapeutics Ltd|Narxning foydaga va o‘sish sur’atiga nisbati Clene Inc.|PepGen Inc. - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori JUNS (Jupiter Neurosciences Inc)|Narxning foydaga va o‘sish sur’atiga nisbati RLMD (Relmada Therapeutics Inc)|Annovis Bio Inc - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Grace Tx (GRCE)|fireflyneuro.com - PEG multiplikatori|Klotho Neurosciences (KLTO) - Narx-foyda va o‘sish multiplikatori|NeuroSense Therapeutics, Ltd. (NRSN) - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati RVPH (Reviva Pharmaceuticals Holdings, Inc.)|MTVA (MetaVia) - PEG multiplikatori|NRXS: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori HSDT|PEG multiplikatori Passage Bio Inc. (PASG)|Narxning foydaga va o‘sish sur’atiga nisbati bionomics.com.au NEUP|PEG multiplikatori Minerva Neurosciences Inc NERV|ATHA: Narx-foyda va o‘sish multiplikatori|ADXN (Addex Therapeutics, Ltd.) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Alzamend Neuro Inc. (ALZN) - Narxning foydaga va o‘sish sur’atiga nisbati|Cyclerion - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati protagenic.com|Pasithea Therapeutics - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori CRGT (Cortigent, Inc.)|Avenue Therapeutics - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Brainstorm Cell BCLI|PEG multiplikatori caratherapeutics.com CARA|Chromocell Therapeutics Corp. - PEG multiplikatori|eliemtx.com - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|Intra-Cellular Therapies (ITCI) - Narxning foydaga va o‘sish sur’atiga nisbati|LBPH (Longboard) - Narxning foydaga va o‘sish sur’atiga nisbati|MRNS (marinuspharma.com) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda NKGen Biotech NKGN|Narxning foydaga va o‘sish sur’atiga nisbati NeuroBo Pharma (NRBO)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati SAGE|Synaptogenix, Inc. - Narx-foyda va o‘sish multiplikatori|TRVN: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|VIGL - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti WENA (Anew Medical, Inc.)|CERE: PEG multiplikatori
